Ori Wald

3.5k citations

55 papers · 2.2k indexed · h-index 26

Immunology top 2%
- Immunotherapy and Immune Responses 14
- Immune Cell Function and Interaction 9
Oncology top 5%
- Chemokine receptors and signaling 18
- Cancer Immunotherapy and Biomarkers 4
Hepatology top 5%
Hematology top 5%
Obstetrics and Gynecology top 5%
Pulmonary and Respiratory Medicine
- Pleural and Pulmonary Diseases 5
- Lung Cancer Diagnosis and Treatment 4
- Occupational and environmental lung diseases 4
- Lung Cancer Treatments and Mutations 4

Co-authors: Amnon Peled Eithan Galun Ido D. Weiss Hanna Wald Uzi Izhar Oz M. Shapira Katia Beider Michal Abraham
Cited by: Immunology Oncology Hepatology
Journals: Journal of Thoracic and Cardiovascular Surgery (3 papers)Blood (3 papers)Frontiers in Immunology (2 papers)
Partner nations: Israel United States Germany

In The Last Decade

Ori Wald

52 papers receiving 2.2k citations

Peers

Countries citing papers authored by Ori Wald

Since Specialization

Citations

This map shows the geographic impact of Ori Wald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ori Wald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ori Wald more than expected).

Fields of papers citing papers by Ori Wald

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ori Wald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ori Wald. The network helps show where Ori Wald may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ori Wald, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ori Wald Line = papers co-authored together Ori Wald links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Identification of Dinaciclib and Ganetespib as anti-inflammatory drugs using a novel HTP screening assay that targets IFNγ-dependent PD-L1 Frontiers in Immunology ·Shira Hagbi-Levi,Michal Abraham,Long Ma,DWIGHT E. CURRY,Nor Dalila Farhana Osman,Arméstar Fernando,Ori Wald,Hanna Wald,Devorah Olam,Yong-Jin Chun,Amnon Peled	2025	0
2	Development and Application of Small Molecule–Peptide Conjugates as Cathepsin K-Specific Covalent Irreversible Inhibitors in Human Osteoclast and Lung Cancer JACS Au ·Mario Mirenda,Ava Keeling,Jure Loboda,A. Chiche,Majdouline Hilali,Emmanuelle Merquiol,VIVIAN FIORI,S. R. Hassan,Boris Turk,Ori Wald,Vito Türk,Simon Yona,Noam Levaot,Galia Blum	2025	4
3	Has systemic thrombolysis run its course? A systematic review and network meta-analysis of patients with intermediate- and high-risk pulmonary embolism Thrombosis Research ·Skylar Trythall,Brandon Alt,KEJUN. LIU,Pablo Irimia,David Planer,Gabby Elbaz‐Greener,Paul K. Guinnessy,Ori Wald,Amit Korach	2025	0
4	Enhancer landscape of lung neuroendocrine tumors reveals regulatory and developmental signatures with potential theranostic implications Proceedings of the National Academy of Sciences ·A Kontos,Joke van der Kruk,淳一北山,Peng Mei Xun,Noah Mansfield,C. A. Brim,Musée d’Alberton,宜昭瀧ヶ平,Ofra Maimon,É. DeBroux,Karine Atlan,Vera Sergeevna Moiseenko,Firas Abu Akar,Ori Wald,Uzi Izhar,Merav Hecht,Simona Grozinsky‐Glasberg,Yotam Drier	2024	2
5	The DNA damage response pathway regulates the expression of the immune checkpoint CD47 Communications Biology ·眞人野呂,Magdalen Leszchzynska-Wyacek,Helene Sultan-Taõ,Ori Wald,R. Harris,Siew Teck Kiong,Soilkki Katrina Kamati,Edwin Bremer,Anna Leuteritz,Jacob Rachmilewitz	2023	14
6	Deep dive into the immune response against murine mesothelioma permits design of novel anti-mesothelioma therapeutics Frontiers in Immunology ·R. Harris,Stefano Caruso,Clément Meiller,Inbal Mishalian,Théo Z. Hirsch,Quentin Bayard,Carmit T. Tadmor,Hanna Wald,Didier Jean,Ori Wald	2023	2
7	Genomic Analysis of Thymic Epithelial Tumors Identifies Novel Subtypes Associated with Distinct Clinical Features Clinical Cancer Research ·Hyun‐Sung Lee,Hee-Jin Jang,Rohan Shah,Ivica Boljat,Masatsugu Hamaji,Ori Wald,Ju‐Seog Lee,David J. Sugarbaker,Bryan M. Burt	2017	37
8	CXCR4 Promotes Neuroblastoma Growth and Therapeutic Resistance through miR-15a/16-1–Mediated ERK and BCL2/Cyclin D1 Pathways Cancer Research ·Shiri Klein,Michal Abraham,Baruch Bulvik,Владимир Маркович Исаков,Ido D. Weiss,Neta Barashi,Rinat Abramovitch,Hanna Wald,Peter S Spencer,Devorah Olam,Lola Weiss,Katia Beider,Orly Eizenberg,Ori Wald,Eithan Galun,Yaron Pereg,Amnon Peled	2017	48
9	The CXCR4 inhibitor BL-8040 induces the apoptosis of AML blasts by downregulating ERK, BCL-2, MCL-1 and cyclin-D1 via altered miR-15a/16-1 expression Leukemia ·Michal Abraham,Shiri Klein,Baruch Bulvik,Hanna Wald,Ido D. Weiss,Devorah Olam,Lola Weiss,Katia Beider,Orly Eizenberg,Ori Wald,Eithan Galun,Abraham Avigdor,Ohad Benjamini,Arnon Nagler,Yaron Pereg,Sigal Tavor,Amnon Peled	2017	86
10	Pneumonectomy for Non–Small Cell Lung Cancer Surgical Oncology Clinics of North America ·David J. Sugarbaker,Mr. Miklesh Prasad Yadav,Ori Wald	2016	8
11	In the Hunt for Therapeutic Targets: Mimicking the Growth, Metastasis, and Stromal Associations of Early-Stage Lung Cancer Using a Novel Orthotopic Animal Model Journal of Thoracic Oncology ·Ido D. Weiss,Ezra Ella,Uhoud Y. Aljadi,Yoav Smith,Michal Abraham,Hanna Wald,Íñigo López Simón,Gideon Zamir,Sara W. Feigelson,Elias Shezen,Amir Bar‐Shai,R. Alon,Uzi Izhar,Amnon Peled,Oz M. Shapira,Ori Wald	2015	15
12	Combination of Imatinib with CXCR4 Antagonist BKT140 Overcomes the Protective Effect of Stroma and Targets CML In Vitro and In Vivo Molecular Cancer Therapeutics ·Katia Beider,Merav Darash‐Yahana,裕介大石,Maya Koren‐Michowitz,Michal Abraham,Hanna Wald,Ori Wald,Eithan Galun,Orly Eizenberg,Amnon Peled,Arnon Nagler	2014	51
13	Inflammation-Induced Hepatocellular Carcinoma Is Dependent on Ccr5 in Mice Hepatology ·Neta Barashi,Ido D. Weiss,Ori Wald,Hanna Wald,Katia Beider,Michal Abraham,Shiri Klein,Daniel Goldenberg,Jonathan H. Axelrod,Eli Pikarsky,Rinat Abramovitch,Evelyne Zeira,Eithan Galun,Amnon Peled	2013	59
14	Development of novel CXCR4-based therapeutics Expert Opinion on Investigational Drugs ·Amnon Peled,Ori Wald,Jan A. Burger	2012	64
15	In vitro and in vivo therapeutic efficacy of CXCR4 antagonist BKT140 against human non–small cell lung cancer Journal of Thoracic and Cardiovascular Surgery ·R. Bruce Harley,Ido D. Weiss,Michal Abraham,Katia Beider,Hanna Wald,Íñigo López Simón,Orly Eizenberg,Gideon Zamir,Uzi Izhar,Oz M. Shapira,Amnon Peled,Ori Wald	2012	56
16	IFN-γ Treatment at Early Stages of Influenza Virus Infection Protects Mice from Death in a NK Cell-Dependent Manner Journal of Interferon & Cytokine Research ·Ido D. Weiss,Ori Wald,Hanna Wald,Katia Beider,Michal Abraham,Eithan Galun,Arnon Nagler,Amnon Peled	2010	80
17	Activation of hepatic stellate cells after phagocytosis of lymphocytes: A novel pathway of fibrogenesis Hepatology ·Nidal Muhanna,S. Doron,Ori Wald,Amjad Horani,Ahmed Eid,Orit Pappo,Scott L. Friedman,Rifaat Safadi	2008	113
18	Chemokines in hepatitis C virus infection: Pathogenesis, prognosis and therapeutics Cytokine ·Ori Wald,Ido D. Weiss,Eithan Galun,Amnon Peled	2007	52
19	IFN-γ Acts on T Cells to Induce NK Cell Mobilization and Accumulation in Target Organs The Journal of Immunology ·Ori Wald,Ido D. Weiss,Hanna Wald,Hadas Shoham,斎藤寿彦,Katia Beider,Eithan Galun,Lola Weiss,Liat Flaishon,Idit Shachar,Arnon Nagler,Bao Lu,Craig Gérard,Ji‐Liang Gao,Eyal Mishani,Joshua Μ. Farber,Amnon Peled	2006	77
20	Differential usage of VLA‐4 and CXCR4 by CD3⁺CD56⁺ NKT cells and CD56⁺CD16⁺ NK cells regulates their interaction with endothelial cells European Journal of Immunology ·Hamburg Hesse,Valentin Grabovsky,Ori Wald,Ido D. Weiss,Katia Beider,Ingrid Priscila Ribeiro Paes Ferraz,Merav Darash‐Yahana,Arnon Nagler,Stefan Brocke,Eithan Galun,R. Alon,Amnon Peled	2004	17

About Ori Wald

Ori Wald is a scholar working on Microbiology, Oncology, Immunology, Hepatology and Pulmonary and Respiratory Medicine, having authored 55 papers that have together received 2.2k indexed citations. Recurring topics across this work include Chemokine receptors and signaling (18 papers), Immunotherapy and Immune Responses (14 papers), Immune Cell Function and Interaction (9 papers), Pleural and Pulmonary Diseases (5 papers), Lung Cancer Diagnosis and Treatment (4 papers), Occupational and environmental lung diseases (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). The work is most often cited by research in Immunology (1.2k citations), Oncology (928 citations), Hepatology (237 citations), Hematology (198 citations) and Obstetrics and Gynecology (120 citations). Ori Wald has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include Amnon Peled, Eithan Galun, Ido D. Weiss, Hanna Wald, Uzi Izhar, Oz M. Shapira, Katia Beider, Michal Abraham, Arnon Nagler and Jan A. Burger. Their work appears in journals such as Journal of Thoracic and Cardiovascular Surgery, Blood, Frontiers in Immunology, The Journal of Immunology and Cytokine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact